Inspiration meets innovation at Brandweek, the ultimate marketing experience. Join industry luminaries, rising talent and strategic experts in Phoenix, Arizona this September 23–26 to assess challenges, develop solutions and create new pathways for growth. Register early to save.
Unilever has outlined why it has tabled three bids, with the latest at around $68 billion, for the Consumer Healthcare division of GlaxoSmithKline (GSK). Following an “extensive” review, the British owner of Ben & Jerry’s, PG Tips, Dove and Lipton Tea has decided that its strategic direction should be to “materially expand” its health, beauty and hygiene offer.
The management and board of Unilever released a statement following press reports of the bid for the health care giant’s division, which GSK claimed “fundamentally undervalues” the business.
“These
WORK SMARTER - LEARN, GROW AND BE INSPIRED.
Spring Special
Save 30% Off an ADWEEK Subscription Today!
Already a member? Sign in